Your browser doesn't support javascript.
loading
The effect of dihydroceramide desaturase 1 inhibition on endothelial impairment induced by indoxyl sulfate.
Savira, Feby; Kompa, Andrew R; Kelly, Darren J; Magaye, Ruth; Xiong, Xin; Huang, Li; Liew, Danny; Reid, Christopher; Kaye, David; Scullino, Carmen V; Pitson, Stuart M; Flynn, Bernard L; Wang, Bing H.
Affiliation
  • Savira F; Biomarker Discovery Laboratory, Baker Heart and Diabetes Research Institute, Melbourne, Australia; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Kompa AR; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Australia.
  • Kelly DJ; Department of Medicine, University of Melbourne, St Vincent's Hospital, Fitzroy, Australia.
  • Magaye R; Biomarker Discovery Laboratory, Baker Heart and Diabetes Research Institute, Melbourne, Australia; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Xiong X; Biomarker Discovery Laboratory, Baker Heart and Diabetes Research Institute, Melbourne, Australia; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Huang L; Biomarker Discovery Laboratory, Baker Heart and Diabetes Research Institute, Melbourne, Australia; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Liew D; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia.
  • Reid C; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia; School of Public Health, Curtin University, Perth, Australia.
  • Kaye D; Heart Failure Research Group, Baker Heart and Diabetes Institute, Melbourne, Australia.
  • Scullino CV; Monash Institute of Pharmaceutical Science, Monash University, Parkville, Australia.
  • Pitson SM; Molecular Signalling Laboratory, Centre for Cancer Biology, University of South Australia, Adelaide, Australia.
  • Flynn BL; Monash Institute of Pharmaceutical Science, Monash University, Parkville, Australia.
  • Wang BH; Biomarker Discovery Laboratory, Baker Heart and Diabetes Research Institute, Melbourne, Australia; Monash Centre of Cardiovascular Research and Education in Therapeutics, School of Public Health and Preventive Medicine, Monash University, Melbourne, Australia. Electronic address: bing.wang@baker.edu
Vascul Pharmacol ; 141: 106923, 2021 12.
Article de En | MEDLINE | ID: mdl-34600152
Sujet(s)
Mots clés
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cellules endothéliales / Indican Limites: Animals Langue: En Journal: Vascul Pharmacol Sujet du journal: ANGIOLOGIA / FARMACOLOGIA Année: 2021 Type de document: Article Pays d'affiliation: Australie Pays de publication: États-Unis d'Amérique
Texte intégral
Ajouter à My VHL
Imprimer
XML
PubMed Links
Recherche sur Google

Texte intégral: 1 Collection: 01-internacional Base de données: MEDLINE Sujet principal: Cellules endothéliales / Indican Limites: Animals Langue: En Journal: Vascul Pharmacol Sujet du journal: ANGIOLOGIA / FARMACOLOGIA Année: 2021 Type de document: Article Pays d'affiliation: Australie Pays de publication: États-Unis d'Amérique